| Literature DB >> 33401488 |
Viviana di Giacomo1, Lucia Recinella1, Annalisa Chiavaroli1, Giustino Orlando1, Amelia Cataldi1, Monica Rapino2, Valentina Di Valerio3, Matteo Politi1, Marco Daniel Antolini1, Alessandra Acquaviva1,4, Francesco Bacchin4, Massimo Di Mascio4, Sheila Leone1, Luigi Brunetti1, Luigi Menghini1, Simone Carradori1, Gokhan Zengin5, Gunes Ak5, Claudio Ferrante1.
Abstract
Industrial hemp is a multiuse crop whose phytocomplex includes terpenophenolics and flavonoids. In the present study, the phenolic and terpenophenolic compounds were assayed in the water extract of the hemp variety Futura 75. Protective effects were also investigated in human fibroblast and keratinocytes and isolate mouse skin specimens, which were exposed to hydrogen peroxide and/or to the extract (1-500 µg/mL). The results of phytochemical analysis suggested the cannabidiol, cannabidiolic acid and rutin as the prominent phytocompounds. In the in vitro system represented by human keratinocytes and fibroblasts, the hemp extract was found to be able to protect cells from cytotoxicity and apoptosis induced by oxidative stress. Moreover, modulatory effects on IL-6, a key mediator in skin proliferation, were found. In isolated rat skin, the extract reduced hydrogen peroxide-induced l-dopa turnover, prostaglandin-E2 production and the ratio kynurenine/tryptpophan, thus corroborating anti-inflammatory/antioxidant effects. The in silico docking studies also highlighted the putative interactions between cannabidiol, cannabidiolic acid and rutin with tyrosinase and indoleamine-2,3-dioxygenase, involved in l-dopa turnover and tryptophan conversion in kynurenine, respectively. In conclusion, the present findings showed the efficacy of hemp water extract as a skin protective agent. This could be partly related to the extract content in cannabidiol, cannabidiolic acid and rutin.Entities:
Keywords: HPLC analysis; IL-6; antioxidant/anti-inflammatory; apoptosis; bioinformatics; indoleamine-2,3-dioxygenase; industrial hemp; keratinocytes; skin disorder(s); tyrosinase
Year: 2021 PMID: 33401488 PMCID: PMC7823476 DOI: 10.3390/antiox10010044
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921